Indeed, NOS1 expression enhanced chemoresistance to cis-diamminedichloroplatinum (cisplatin/DDP) in ovarian cancer and inhibited the interferon response of lung cancer cells [52–54]. The gene discussed is NOS1; the disease is lung cancer.